A Phase I, Single Center, Open Label, Single-Dose, Five-Period Study to Compare the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Apr 2012
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Pharmacokinetics
- Sponsors NuPathe
- 11 Dec 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2008 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 12 Aug 2008 New trial record.